BioShares Biotechnology Clinical Trials ETF (BBC) ETF
BBC - Profile & Info
The investment objective of the Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. The clinical trials index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development.
|Assets Under Management (AUM)||37.97M|
|Underlying Index||BioShares Biotechnology Clinical Trials Index|
|Asset Class||Portfolio-Multi Asset|
|ETF Category||Health & Biotech ETFs|
|Net Asset Value (NAV)||$37.97|
BBC - Top Holdings
BBC - Top Stories
View All BBC News
BBC - Price/Volume Stats
BBC - Recent Returns
BBC - Stock Chart
BBC - Dividends
|Ex-Dividend Date||Type||Payout Amount||Change|
|Loading, please wait...|
Get Free Updates
Most Popular Articles
- Natural Gas Prices Plummet, is it Oversold?
- Why a Breakout for Silver is Likely Within the Next 12 Months
- Will Natural Gas Fall Even Lower?